- Home
- LMND vs INDV Comparison
LMND vs INDV Comparison
Compare LMND & INDV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | LMND | INDV |
|---|---|---|
| Founded | 2015 | N/A |
| Country | United States | United States |
| Employees | 1282 | N/A |
| Industry | Property-Casualty Insurers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.0B | 3.7B |
| IPO Year | N/A | 2014 |
Fundamental Metrics
Financial Performance| Metric | LMND | INDV |
|---|---|---|
| Price | $56.37 | $37.43 |
| Analyst Decision | Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $70.86 | N/A |
| AVG Volume (30 Days) | ★ 1.6M | 1.3M |
| Earning Date | 04-29-2026 | 06-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 8100.00 |
| EPS | N/A | ★ 1.64 |
| Revenue | N/A | ★ $1,239,000,000.00 |
| Revenue This Year | $65.20 | N/A |
| Revenue Next Year | $33.31 | N/A |
| P/E Ratio | ★ N/A | $20.91 |
| Revenue Growth | N/A | ★ 4.29 |
| 52 Week Low | $28.71 | $10.91 |
| 52 Week High | $99.90 | $38.00 |
Technical Indicators
Market Signals| Indicator | LMND | INDV |
|---|---|---|
| Relative Strength Index (RSI) | 38.83 | 72.08 |
| Support Level | $49.67 | $32.43 |
| Resistance Level | $59.42 | $37.83 |
| Average True Range (ATR) | 3.74 | 1.41 |
| MACD | -0.87 | 0.46 |
| Stochastic Oscillator | 13.83 | 79.34 |
Price Performance
Historical ComparisonAbout LMND Lemonade Inc.
Lemonade Inc operates in the insurance industry. The company offers digital and artificial intelligence based platform for various insurances and for settling claims and paying premiums. The platform ensures transparency in issuing policies and settling disputes. The company is using technology, data, artificial intelligence, contemporary design, and social impact to deliver delightful and affordable insurances. The Company operates in one report segment providing personal property and casualty insurance products within the United States and Europe, including the UK.
About INDV Indivior PLC
Indivior Pharmaceuticals Inc is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease. The company derives revenues from customers through the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence and related disorders. The company's products include: Sublocade (buprenorphine extended-release monthly injection), and Suboxone (buprenorphine and naloxone sublingual film).